Across TCGA pan-cancer cohorts, EEF1A1P32 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of EEF1A1P32’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where EEF1A1P32 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EEF1A1P32 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.

HNSC, KICH, and COAD are the cancer types where EEF1A1P32 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1A1P32 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.039	.011	6	view →
KICH	Male	IV	+0.070	.010	5	view →
COAD	All	All	+0.116	.016	2	view →
CHOL	All	II,III,IV	+0.075	.004	2	view →
STAD	Male	IV	−0.245	.038	1	view →
THCA	All	All	−0.023	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: EEF1A1P32 RNA expression & survival · all EEF1A1P32 data types